However, regarding the expression of CD38, as lesser known part of the purinergic system, we observed CD38 expression was significantly reduced in subpopulations of B-cells and Treg cells in the B-ALL compared to HD, regardless of the risk group (SR, IR or HR). This evidence concerns the gene CD38 and acute lymphoblastic leukemia.